EZH2 and breast cancer: In contrast, two N-terminal domains of EZH2 interacts directly with β-catenin and estrogen receptor alpha (ERα), and thus links the Wnt and estrogen signaling pathways, leading to gene transactivation and cell cycle progression in breast cancer cells [22].